BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20551327)

  • 1. Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.
    He Y; Wortmann A; Burke LJ; Reid JC; Adams MN; Abdul-Jabbar I; Quigley JP; Leduc R; Kirchhofer D; Hooper JD
    J Biol Chem; 2010 Aug; 285(34):26162-73. PubMed ID: 20551327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.
    Casar B; He Y; Iconomou M; Hooper JD; Quigley JP; Deryugina EI
    Oncogene; 2012 Aug; 31(35):3924-38. PubMed ID: 22179830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
    Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
    Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.
    He Y; Reid JC; He H; Harrington BS; Finlayson B; Khan T; Hooper JD
    Biol Chem; 2018 Sep; 399(9):1091-1097. PubMed ID: 29447112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
    Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
    Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
    Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
    J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.
    Kollmorgen G; Bossenmaier B; Niederfellner G; Häring HU; Lammers R
    PLoS One; 2012; 7(12):e53050. PubMed ID: 23300860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.
    Nelson LJ; Wright HJ; Dinh NB; Nguyen KD; Razorenova OV; Heinemann FS
    Am J Pathol; 2020 Feb; 190(2):484-502. PubMed ID: 31843498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
    Gandji LY; Proust R; Larue L; Gesbert F
    PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
    Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
    Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
    Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
    Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
    Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
    Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
    Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.
    Yang L; Dutta SM; Troyer DA; Lin JB; Lance RA; Nyalwidhe JO; Drake RR; Semmes OJ
    Oncotarget; 2015 Dec; 6(41):43743-58. PubMed ID: 26497208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
    Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
    Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer.
    McKinley ET; Liu H; McDonald WH; Luo W; Zhao P; Coffey RJ; Hanks SK; Manning HC
    PLoS One; 2013; 8(11):e80207. PubMed ID: 24260357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
    Kollmorgen G; Niederfellner G; Lifke A; Spohn GJ; Rieder N; Harring SV; Bauss F; Burtscher H; Lammers R; Bossenmaier B
    Mol Oncol; 2013 Dec; 7(6):1142-51. PubMed ID: 24055141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation.
    Nakashima K; Uekita T; Yano S; Kikuchi JI; Nakanishi R; Sakamoto N; Fukumoto K; Nomoto A; Kawamoto K; Shibahara T; Yamaguchi H; Sakai R
    Cancer Sci; 2017 May; 108(5):1049-1057. PubMed ID: 28256037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.